Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Siebenhofer, A; Horvath, K; Kraly, B; Plank, J.
Diabetes and drug treatment of hypertension
Wien Med Wochenschr. 2003; 153(21-22): 464-468.
Doi: 10.1007/s10354-003-0036-x
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Siebenhofer-Kroitzsch Andrea
- Co-Autor*innen der Med Uni Graz
- Horvath Karl
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- In hypertensive diabetic patients, reducing blood pressure is among the best evaluated and most effective interventions for lowering mortality and morbidity. First line antihypertensive agents are: chlorthalidone or other thiazide-type diuretics, beta-blockers and ACE-inhibitors. In type 2 diabetic patients with left ventricular hypertrophy, the ARB Cosaar has been proven to be effective. To achieve an effective blood pressure reduction, a combination of different antihypertensive agents is necessary for most patients. Specially structured patient education programmes are another effective means of achieving this goal.
- Find related publications in this database (using NLM MeSH Indexing)
- Adrenergic beta-Antagonists - adverse effects
- Angiotensin-Converting Enzyme Inhibitors - adverse effects
- Antihypertensive Agents - adverse effects
- Benzothiadiazines - adverse effects
- Cause of Death - adverse effects
- Chlorthalidone - adverse effects
- Diabetes Mellitus, Type 2 - drug therapy
- Diuretics - drug therapy
- Drug Therapy, Combination - drug therapy
- Humans - drug therapy
- Hypertension - drug therapy
- Randomized Controlled Trials as Topic - drug therapy
- Sodium Chloride Symporter Inhibitors - adverse effects
- Survival Rate - adverse effects